The Lung Institute Provides A New Lease On Life

The Lung Institute was founded to give individuals suffering from chronic lung and respiratory illnesses an opportunity to live a healthier and happier life. Some of the chronic lung diseases studied by The Lung Institute include: chronic obstructive pulmonary disease known as COPD, pulmonary fibrosis, and interstitial lung disease.

Patients of The Long Institute are treated with autologous stem cells. According to The Long Institute, autologous stem cells are blank cells that have not be assigned to any function yet. These special cells have the ability to renew and heal themselves. By using autologous stem cells, patients can heal from their body’s own cells. These healthy cells not only ease the symptoms of lung disease, but also work to stop the progression of the disease.

Traditional respiratory treatments only targeted the symptoms associated with the respiratory disease; as opposed to treating the disease itself. Patients treated for respiratory illnesses often suffered for years due to a lack of knowledge and research on properly treating the progression of the disease. Patients of The Lung Institute have access to great tools for education and empowerment. The Long Institute continues to lead in adult stem cell research for chronic lung diseases; offering articles, advice and resources to enrich the lives of those suffering from lung disease.

The Lung Institute ensures that every patient is screened thoroughly and is treated with a unique approach. The Lung Institute focuses on using current condition and medical history from the past to make sure that each stem cell treatment gets the best possible results.

For more information about The Lung Institute you can visit:

The Lung Institute About Page:

About

The Lung Institute Autologous Cells Page:

https://lunginstitute.com/blog/what-are-autologous-stem-cells-2/

https://www.cedars-sinai.edu/Patients/Programs-and-Services/Lung-Institute/

Also check out the Institute’s Twitter page and YouTube channel for more info.

 

Oncotarget’s Struggle for A Cancer-Free World Bearing Fruits

Oncotarget is a peer-reviewed medical journal founded in 2010. Oncotarget is published on a weekly basis by Impact Journals and covers oncology research on bioxbio.com. Most importantly, Oncotarget focuses on research involving treatments and protocols deployed to enhance the well-being of cancer patients, potential therapy targets, as well as the clinical basis of all strains of cancer. Oncotarget adheres to the principles of COPE (Committee on Publication Ethics) and is a member of the body. The impact publication project seeks to define the healthcare professionals and patient acceptance of new as well as existing drugs, treatment methods, and available forms of therapy. Oncotarget tries to improve the lives of cancer patients and to improve the outcomes of these procedures by discovering new information.

Oncotarget places emphasis on patient perspectives vis-à-vis satisfaction, adherence, and their quality of life. They employ certain treatment protocols, existing therapeutic agents, as well as the impact of management programs on the lives of patients. The journal’s recent success on the oncology front has led to the exploration of other medical fields. Oncotarget is dedicated to the attainment of a world without disease under the leadership of a group of elite researchers and scientists from the world over. The journal advocates for the use of basic clinical science to eradicate disease and break boundaries within medical specialties on ncbi.nlm.nih.gov towards quicker discoveries and make scientific research widely and rapidly available.

On E-cigarettes and Alleged Damage to Gum Tissue

A recent survey on msubmit.net on the effects of e-cigarettes financed by National Institutes of Health was published on Oncotarget. The research, which was conducted under the leadership of UR’s Department of Environmental Medicine professor Irfan Rahman (Ph.D.), was the first ever on the subject on molecular and cellular levels. E-cigarettes are known to be the safer option, popular among people struggling to quit smoking and the younger generation. However, this particular study shows that e-cigarettes can cause multiple oral infections and cell damage.

The problem with e-cigarettes according to the study is the flavoring which damages the gums. The lead scientists urged manufacturers to disclose all the compounds used to manufacture the flavors so that more research can be carried out on the effects of e-cigarettes. Apart from this specific study, a growing body of scientific data suggests that the chemicals found in e-cigarettes have the potential effects of adverse health conditions associated with convention smokes. Professor Rahman also published another study with similar findings on pollution and health effects of e-cigarettes in late 2015.